Weinong Guo is the Senior Vice President of Clinical Development at Alnylam Pharmaceuticals, where he leads the advancement of RNAi programs for cardiometabolic diseases. His extensive career includes a 14-year tenure at Novartis, where he played a key role in developing major cardiovascular drugs. He holds an MD from Soochow University and a PhD from Nagoya University.
Originally from China, Weinong travels back whenever possible to visit his parents in Suzhou. He is personally motivated by their long-term struggle with hypertension, which has been difficult to control with traditional daily medications. This firsthand experience with the challenges of chronic disease management fuels his professional passion.
His work developing a twice-yearly injectable treatment for hypertension is directly inspired by his parents health struggles.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.